We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£890.00
The 2027-2032 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma
Price data last checked 52 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£890 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 39 days • 39 data points (No recent data available)
Price Distribution
Price distribution over 39 days • 1 price levels
Price Analysis
Most common price: £890 (39 days, 100.0%)
Price range: £890 - £890
Price levels: 1 different prices over 39 days
Product Specifications
- Format
- paperback
- ASIN
- B0GPQF9JCR
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 05 January 2026
- Listed Since
- 23 February 2026
Similar Products You Might Like
The 2027-2032 World Outlook for Malignant Mesothelioma
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
The 2021-2026 World Outlook for Silent Cancer Therapeutics
The 2021-2026 World Outlook for Lung Cancer Therapeutics
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
The 2025-2030 World Outlook for Immune-Oncology Treatments
The 2023-2028 Outlook for Lung Cancer Screening Software in the United States
The 2013-2018 Outlook for Melanoma Therapeutics in India
The 2023-2028 Outlook for Cancer Screenings in the United States
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
The 2023-2028 World Outlook for Advanced Therapy Medicinal Products
The 2026-2031 World Outlook for Medical Terminology Software
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
